Vivo Bio Tech Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 126.73 million compared to INR 101.68 million a year ago. Revenue was INR 126.79 million compared to INR 101.98 million a year ago. Net income was INR 1.21 million compared to INR 2.77 million a year ago. Basic earnings per share from continuing operations was INR 0.08 compared to INR 0.2 a year ago. Diluted earnings per share from continuing operations was INR 0.08 compared to INR 0.19 a year ago.
For the six months, sales was INR 239.36 million compared to INR 231.65 million a year ago. Revenue was INR 239.43 million compared to INR 234.16 million a year ago. Net income was INR 4.37 million compared to INR 15.17 million a year ago. Basic earnings per share from continuing operations was INR 0.3 compared to INR 1.07 a year ago. Diluted earnings per share from continuing operations was INR 0.3 compared to INR 1.02 a year ago.